Kevin J. Ballinger, SVP & President, Interven Cardio at BOSTON SCIENTIFIC CORP (BSX), sold 67,964 shares at $17.91 ($1.2M) on 2015-05-04, disclosed to the SEC on 2015-05-06.
Open-market sale of $1.2M BSX by SVP & President, Interven Cardio. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BSX | SELL | 2020-03-03 | $1.2M | — | Filing → |
| BSX | SELL | 2020-02-26 | $466K | — | Filing → |
| BSX | SELL | 2020-02-19 | $149K | — | Filing → |